All four drugs Ozempic, Wegovy, Mounjaro and Zepbound still remain on the health regulators drug shortage, despite all but one dose of Wegovy being listed as currently available on the site
[42] A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight
Peptide therapy is generally more affordable and easier to incorporate into a sustainable wellness routine
As breakthrough medications like Wegovy (semaglutide) or Ozempic (semaglutide) and Mounjaro (tirzepatide) or Zepbound (tirzepatide) transform obesity management, new questions arise: Can these medications indirectly improve autoimmune conditions by lowering inflammation
The STEP 5 trial assessed the efficacy and safety of once-weekly subcutaneous semaglutide 2.4 mg versus placebo (both plus behavioral intervention) for long-term treatment of adults with obesity, or overweight with at least one weight-related comorbidity, without diabetes
But also in the course, we're going deeper on conversations like, um, if you need to consider hormone replacement therapy, how to talk to your doctor about that, like what you should be considering and what never to do